152 related articles for article (PubMed ID: 38013600)
1. METTL3/YTHDF2 m6A axis mediates the progression of diabetic nephropathy through epigenetically suppressing PINK1 and mitophagy.
Wang F; Bai J; Zhang X; Wang D; Zhang X; Xue J; Chen H; Wang S; Chi B; Li J; Ma X
J Diabetes Investig; 2024 Mar; 15(3):288-299. PubMed ID: 38013600
[TBL] [Abstract][Full Text] [Related]
2. Huangkui capsule attenuates diabetic kidney disease through the induction of mitophagy mediated by STING1/PINK1 signaling in tubular cells.
Zhu Z; Luan G; Peng S; Fang Y; Fang Q; Shen S; Wu K; Qian S; Jia W; Ye J; Wei L
Phytomedicine; 2023 Oct; 119():154975. PubMed ID: 37517171
[TBL] [Abstract][Full Text] [Related]
3. JinChan YiShen TongLuo Formula ameliorate mitochondrial dysfunction and apoptosis in diabetic nephropathy through the HIF-1α-PINK1-Parkin pathway.
Qiyan Zheng ; Zhang X; Guo J; Wang Y; Jiang Y; Li S; Liu YN; Liu WJ
J Ethnopharmacol; 2024 Jun; 328():117863. PubMed ID: 38325670
[TBL] [Abstract][Full Text] [Related]
4. METTL3-Mediated N6-Methyladenosine Methylation Modifies Foxp3 mRNA Levels and Affects the Treg Cells Proportion in Peripheral Blood of Patients with Asthma.
Fan L; Wu J; Wang H; Chen Q; He X; Wang Q; Yang Z
Ann Clin Lab Sci; 2022 Nov; 52(6):884-894. PubMed ID: 36564065
[TBL] [Abstract][Full Text] [Related]
5. Human aortic smooth muscle cell regulation by METTL3 via upregulation of m6A NOTCH1 modification and inhibition of NOTCH1.
Yang J; Fang M; Yu C; Li Z; Wang Q; Li C; Wu J; Fan R
Ann Transl Med; 2023 Aug; 11(10):350. PubMed ID: 37675298
[TBL] [Abstract][Full Text] [Related]
6. METTL3-mediated m
Jiang L; Liu X; Hu X; Gao L; Zeng H; Wang X; Huang Y; Zhu W; Wang J; Wen J; Meng X; Wu Y
Mol Ther; 2022 Apr; 30(4):1721-1740. PubMed ID: 34995800
[TBL] [Abstract][Full Text] [Related]
7. METTL3-Mediated N6-Methyladenosine Modification of lncRNA D26496 Suppresses the Proliferation and Migration of Schwann Cells after Sciatic Nerve Injury.
He X; Zhang J; Guo Y; Yang X; Huang Y; Hao D
Mol Neurobiol; 2023 May; 60(5):2413-2425. PubMed ID: 36656457
[TBL] [Abstract][Full Text] [Related]
8. METTL3/YTHDF2 m6A axis promotes the malignant progression of bladder cancer by epigenetically suppressing RRAS.
Chen JX; Chen DM; Wang D; Xiao Y; Zhu S; Xu XL
Oncol Rep; 2023 May; 49(5):. PubMed ID: 36960869
[TBL] [Abstract][Full Text] [Related]
9. METTL3 relieved the injury of SH-SY5Y cells treated with lipopolysaccharide and exposed to sevoflurane through regulating the m6A levels of Sox2.
Wang Y; Yang Z
Brain Behav; 2023 May; 13(5):e2936. PubMed ID: 36977205
[TBL] [Abstract][Full Text] [Related]
10. METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing.
Wang X; Wang J; Zhao X; Wu H; Li J; Cheng Y; Guo Q; Cao X; Liang T; Sun L; Zhang G
J Transl Med; 2023 Jun; 21(1):407. PubMed ID: 37353804
[TBL] [Abstract][Full Text] [Related]
11. The KLF4-p62 axis prevents vascular endothelial cell injury via the mTOR/S6K pathway and autophagy in diabetic kidney disease.
Wang X; Su W; Ma M; Zhu L; Gao R; Qin C; Shao S; Gao D; Gao J; Zhang Z
Endokrynol Pol; 2022; 73(5):837-845. PubMed ID: 36621906
[TBL] [Abstract][Full Text] [Related]
12. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
13. Silencing of METTL3 prevents the proliferation, migration, epithelial-mesenchymal transition, and renal fibrosis of high glucose-induced HK2 cells by mediating WISP1 in m6A-dependent manner.
Chen Y; Li P; Lin M; Jiang Y; Tan G; Huang L; Song D
Aging (Albany NY); 2024 Jan; 16(2):1237-1248. PubMed ID: 38289593
[TBL] [Abstract][Full Text] [Related]
14. METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy.
Sun Y; Shen W; Hu S; Lyu Q; Wang Q; Wei T; Zhu W; Zhang J
J Exp Clin Cancer Res; 2023 Mar; 42(1):65. PubMed ID: 36932427
[TBL] [Abstract][Full Text] [Related]
15. CERS6-derived ceramides aggravate kidney fibrosis by inhibiting PINK1-mediated mitophagy in diabetic kidney disease.
Wang X; Song M; Li X; Su C; Yang Y; Wang K; Liu C; Zheng Z; Jia Y; Ren S; Dong W; Chen J; Wang T; Liu L; Guan M; Zhang C; Xue Y
Am J Physiol Cell Physiol; 2023 Aug; 325(2):C538-C549. PubMed ID: 37458434
[TBL] [Abstract][Full Text] [Related]
16. Scutellarin ameliorates high glucose-induced vascular endothelial cells injury by activating PINK1/Parkin-mediated mitophagy.
Xi J; Rong Y; Zhao Z; Huang Y; Wang P; Luan H; Xing Y; Li S; Liao J; Dai Y; Liang J; Wu F
J Ethnopharmacol; 2021 May; 271():113855. PubMed ID: 33485979
[TBL] [Abstract][Full Text] [Related]
17. METTL3 enhances NSD2 mRNA stability to reduce renal impairment and interstitial fibrosis in mice with diabetic nephropathy.
Tang W; Zhao Y; Zhang H; Peng Y; Rui Z
BMC Nephrol; 2022 Mar; 23(1):124. PubMed ID: 35354439
[TBL] [Abstract][Full Text] [Related]
18. Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2-dependent mechanism.
Ni WJ; Zhou H; Lu H; Ma NN; Hou BB; Li W; Kong FX; Yu JT; Hou R; Jin J; Wen JG; Zhang T; Meng XM
Clin Transl Med; 2023 Aug; 13(8):e1359. PubMed ID: 37537731
[TBL] [Abstract][Full Text] [Related]
19. METTL3-regulated m6A modification impairs the decidualization of endometrial stromal cells by regulating YTHDF2-mediated degradation of FOXO1 mRNA in endometriosis-related infertility.
Li X; Jin J; Long X; Weng R; Xiong W; Liang J; Liu J; Sun J; Cai X; Zhang L; Liu Y
Reprod Biol Endocrinol; 2023 Oct; 21(1):99. PubMed ID: 37891533
[TBL] [Abstract][Full Text] [Related]
20. METTL3/IGF2BP2 axis affects the progression of colorectal cancer by regulating m6A modification of STAG3.
Yi J; Peng F; Zhao J; Gong X
Sci Rep; 2023 Oct; 13(1):17292. PubMed ID: 37828232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
